Ignite Creation Date:
2025-12-24 @ 9:47 PM
Ignite Modification Date:
2026-02-03 @ 6:43 AM
Study NCT ID:
NCT03237832
Status:
COMPLETED
Last Update Posted:
2017-08-03
First Post:
2017-07-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of ARN-6039
Sponsor:
Arrien Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ARN-CLN-0001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |